Molecular Influence of the ATM Protein in the Treatment of Human Cells with Different Radioprotective Drugs: Comparisons between Antioxidative and Pro-Episkevic Strategies.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
13 03 2023
Historique:
received: 12 09 2022
revised: 03 03 2023
accepted: 09 03 2023
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

The radiation protection strategy with chemical agents has long been based on an antioxidative approach consisting in reducing the number of radical oxygen and nitrogen species responsible for the formation of the radiation-induced (RI) DNA damage, notably the DNA double-strand breaks (DSB), whose subset participates in the RI lethal effect as unrepairable damage. Conversely, a DSB repair-stimulating strategy that may be called the "pro-episkevic" approach (from the ancient Greek

Identifiants

pubmed: 36979459
pii: biom13030524
doi: 10.3390/biom13030524
pmc: PMC10046588
pii:
doi:

Substances chimiques

Ataxia Telangiectasia Mutated Proteins EC 2.7.11.1
Radiation-Protective Agents 0
Antioxidants 0
Amifostine M487QF2F4V
ATM protein, human EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Int J Radiat Biol. 2014 Jul;90(7):594-604
pubmed: 24597748
Mutat Res Rev Mutat Res. 2016 Oct - Dec;770(Pt B):369-386
pubmed: 27919342
Hum Genet. 1987 Mar;75(3):197-208
pubmed: 3549535
Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):450-60
pubmed: 26867874
Expert Opin Drug Saf. 2019 Nov;18(11):1077-1090
pubmed: 31526195
Curr Eye Res. 2021 Apr;46(4):546-557
pubmed: 32862699
J Cell Sci. 2009 Jul 15;122(Pt 14):2337-50
pubmed: 19571113
J Environ Pathol Toxicol Oncol. 2015;34(1):53-61
pubmed: 25746831
Cell Death Dis. 2017 Aug 10;8(8):e2978
pubmed: 28796249
Curr Neuropharmacol. 2021;19(8):1202-1224
pubmed: 33380301
Int J Radiat Biol. 1997 Sep;72(3):271-83
pubmed: 9298107
Mol Neurobiol. 2018 Jun;55(6):4973-4983
pubmed: 28786016
Int J Mol Sci. 2021 Apr 03;22(7):
pubmed: 33916740
Future Oncol. 2022 Jun;18(18):2257-2267
pubmed: 35414201
Radiat Res. 1989 Oct;120(1):154-63
pubmed: 2798778
J Clin Oncol. 1993 Aug;11(8):1517-22
pubmed: 8393097
Int J Radiat Biol. 2020 Mar;96(3):394-410
pubmed: 31738647
World J Gastroenterol. 2014 Aug 7;20(29):10158-65
pubmed: 25110444
Int J Radiat Biol. 2020 May;96(5):661-670
pubmed: 31990607
EMBO J. 2003 Jun 2;22(11):2860-71
pubmed: 12773400
Semin Oncol. 2005 Apr;32(2 Suppl 3):S99-104
pubmed: 16015543
Mol Neurobiol. 2014 Jun;49(3):1200-11
pubmed: 24277524
Int J Radiat Oncol Biol Phys. 1976 Jul-Aug;1(7-8):699-703
pubmed: 185172
Redox Rep. 2009;14(3):115-24
pubmed: 19490753
Int J Radiat Biol. 2021;97(3):317-328
pubmed: 33320757
Redox Biol. 2019 Jul;25:101084
pubmed: 30612957
N Am J Med Sci. 2015 Nov;7(11):483-93
pubmed: 26713296
Int J Radiat Oncol Biol Phys. 1998 Apr 1;41(1):3-5
pubmed: 9588910
Pharmacol Ther. 1988;39(1-3):13-20
pubmed: 3059363
Mol Cancer Ther. 2018 Feb;17(2):407-418
pubmed: 29030460
Mol Neurobiol. 2022 Jan;59(1):556-573
pubmed: 34727321
Radiat Environ Biophys. 2017 Nov;56(4):405-412
pubmed: 28871381
Curr Drug Metab. 2021;22(5):328-341
pubmed: 33459228
Int J Mol Sci. 2022 Jan 29;23(3):
pubmed: 35163494
Arch Gynecol Obstet. 2014 Jan;289(1):193-200
pubmed: 23880890
Int J Radiat Biol. 1996 Feb;69(2):241-9
pubmed: 8609461
N Engl J Med. 1983 Nov 10;309(19):1137-41
pubmed: 6312315
J Theor Biol. 2016 Apr 7;394:93-101
pubmed: 26807808
Pharmacol Ther. 2021 Dec;228:107916
pubmed: 34171332
Int J Radiat Biol. 2016;92(3):117-31
pubmed: 26907628
J Cell Biol. 2018 Jul 2;217(7):2291-2298
pubmed: 29915025
Int J Radiat Biol Relat Stud Phys Chem Med. 1986 Jan;49(1):85-101
pubmed: 3484471
J Radiat Res. 2009 Jan;50(1):43-50
pubmed: 19218780
Oncology. 2020;98(2):61-80
pubmed: 31846959
Cancers (Basel). 2019 Jun 28;11(7):
pubmed: 31261657
Int J Radiat Biol. 2008 Feb;84(2):107-25
pubmed: 18246480
Arch Toxicol. 2022 May;96(5):1227-1255
pubmed: 35199244
Int J Mol Sci. 2022 Sep 09;23(18):
pubmed: 36142346
Int J Radiat Oncol Biol Phys. 1985 May;11(5):1035-8
pubmed: 2985525
Environ Health Perspect. 1997 Dec;105 Suppl 6:1473-8
pubmed: 9467066
Radiat Res. 1983 Jan;93(1):175-83
pubmed: 6296910
Int J Radiat Biol. 2009 Jul;85(7):539-73
pubmed: 19557599
Mol Aspects Med. 2009 Feb-Apr;30(1-2):1-12
pubmed: 18796312
Radiother Oncol. 1992 Nov;25(3):192-5
pubmed: 1335155
Int J Mol Sci. 2019 Oct 26;20(21):
pubmed: 31717816
Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5057-62
pubmed: 12679524
Eur J Cancer. 1994;30A(2):183-7
pubmed: 8155393
Int J Mol Sci. 2017 Sep 15;18(9):
pubmed: 28914798
Cancer Res. 1997 Oct 15;57(20):4600-7
pubmed: 9377575
Radiat Res. 2007 Jul;168(1):106-14
pubmed: 17723002
Mutat Res. 2011 Jun 3;711(1-2):193-201
pubmed: 21216256
Oncologist. 2010;15(4):360-71
pubmed: 20413641
Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5331-40
pubmed: 17875761
Int J Radiat Biol Relat Stud Phys Chem Med. 1987 Dec;52(6):847-52
pubmed: 3500925
Nat Med. 2008 Jul;14(7):767-72
pubmed: 18587406
J Radiat Res. 2001 Mar;42(1):21-37
pubmed: 11393887
Antioxidants (Basel). 2021 Jun 16;10(6):
pubmed: 34208683
Biochim Biophys Acta. 2013 Aug;1830(8):4117-29
pubmed: 23618697

Auteurs

Juliette Restier-Verlet (J)

INSERM U1296 Unit "Radiation: Defense, Health, Environment", Centre Léon-Bérard, 69008 Lyon, France.

Michel Drouet (M)

INSERM U1296 Unit "Radiation: Defense, Health, Environment", Centre Léon-Bérard, 69008 Lyon, France.
Division Défense NRBC, Institut de Recherche Biomédicale des Armées, 91220 Brétigny-sur-Orge, France.

Pauline Pras (P)

INSERM U1296 Unit "Radiation: Defense, Health, Environment", Centre Léon-Bérard, 69008 Lyon, France.

Mélanie L Ferlazzo (ML)

INSERM U1296 Unit "Radiation: Defense, Health, Environment", Centre Léon-Bérard, 69008 Lyon, France.

Adeline Granzotto (A)

INSERM U1296 Unit "Radiation: Defense, Health, Environment", Centre Léon-Bérard, 69008 Lyon, France.

Laurène Sonzogni (L)

INSERM U1296 Unit "Radiation: Defense, Health, Environment", Centre Léon-Bérard, 69008 Lyon, France.

Joëlle Al-Choboq (J)

INSERM U1296 Unit "Radiation: Defense, Health, Environment", Centre Léon-Bérard, 69008 Lyon, France.

Laura El Nachef (L)

INSERM U1296 Unit "Radiation: Defense, Health, Environment", Centre Léon-Bérard, 69008 Lyon, France.

Sabine François (S)

INSERM U1296 Unit "Radiation: Defense, Health, Environment", Centre Léon-Bérard, 69008 Lyon, France.
Division Défense NRBC, Institut de Recherche Biomédicale des Armées, 91220 Brétigny-sur-Orge, France.

Michel Bourguignon (M)

INSERM U1296 Unit "Radiation: Defense, Health, Environment", Centre Léon-Bérard, 69008 Lyon, France.
Department of Biophysics and Nuclear Medicine, Université Paris Saclay Versailles St Quentin en Yvelines, 78035 Versailles, France.

Nicolas Foray (N)

INSERM U1296 Unit "Radiation: Defense, Health, Environment", Centre Léon-Bérard, 69008 Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH